Robert B. Reynolds

421 total citations
10 papers, 314 citations indexed

About

Robert B. Reynolds is a scholar working on Molecular Biology, Biochemistry and Surgery. According to data from OpenAlex, Robert B. Reynolds has authored 10 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Biochemistry and 1 paper in Surgery. Recurrent topics in Robert B. Reynolds's work include Eicosanoids and Hypertension Pharmacology (2 papers), Protein purification and stability (1 paper) and Advanced Breast Cancer Therapies (1 paper). Robert B. Reynolds is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (2 papers), Protein purification and stability (1 paper) and Advanced Breast Cancer Therapies (1 paper). Robert B. Reynolds collaborates with scholars based in United States. Robert B. Reynolds's co-authors include Jonathan R. Mielenz, Stephen Picataggio, L. Dudley Eirich, Samuel M. Poloyac, Howard Yonas, Mary E. Kerr, Wen Xie, Michael A. Zemaitis, Michael A. Tortorici and Reginald F. Frye and has published in prestigious journals such as Nature Biotechnology, Journal of Marketing and Cancer Research.

In The Last Decade

Robert B. Reynolds

9 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Reynolds United States 5 197 76 61 40 36 10 314
Minhye Kim South Korea 12 200 1.0× 50 0.7× 14 0.2× 17 0.4× 34 0.9× 32 405
Tetsuji Nakamura Japan 13 349 1.8× 61 0.8× 46 0.8× 23 0.6× 7 0.2× 18 440
Ondřej Kaplan Czechia 18 517 2.6× 83 1.1× 131 2.1× 7 0.2× 28 0.8× 28 664
Amal Kumar Bandyopadhyay India 10 190 1.0× 78 1.0× 38 0.6× 9 0.2× 118 3.3× 13 406
Simone Marques Bolonheis Brazil 9 151 0.8× 29 0.4× 11 0.2× 17 0.4× 22 0.6× 10 400
Isabelle Fries France 11 88 0.4× 37 0.5× 45 0.7× 4 0.1× 52 1.4× 16 360
Vijay Mani India 10 88 0.4× 57 0.8× 17 0.3× 45 1.1× 7 0.2× 25 302
Witcha Imaram United States 9 108 0.5× 28 0.4× 20 0.3× 10 0.3× 8 0.2× 16 350
Xiulong Deng China 10 107 0.5× 75 1.0× 8 0.1× 20 0.5× 68 1.9× 18 343
Jung Eun Kwon South Korea 11 126 0.6× 40 0.5× 13 0.2× 25 0.6× 40 1.1× 43 366

Countries citing papers authored by Robert B. Reynolds

Since Specialization
Citations

This map shows the geographic impact of Robert B. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Reynolds more than expected).

Fields of papers citing papers by Robert B. Reynolds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Reynolds. The network helps show where Robert B. Reynolds may publish in the future.

Co-authorship network of co-authors of Robert B. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Reynolds. A scholar is included among the top collaborators of Robert B. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Reynolds. Robert B. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mori, Shahram, Rushang D. Patel, Ahmed Zakari, et al.. (2018). Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 24(3). S237–S237.
2.
Litherland, Sally A., Robert B. Reynolds, Louis H. Barr, Alvin J.O. Almodovar, & David A. Decker. (2015). Abstract P4-01-15: Assay Development for detection of estrogen responsive gene histone acetylation in breast cancer circulating tumor cells. Cancer Research. 75(9_Supplement). P4–1. 1 indexed citations
3.
Bigsby, Glenn E., et al.. (2005). Endometroid adenocarcinoma of the uterus with cardiac metastasis. Gynecologic Oncology. 97(1). 256–259. 7 indexed citations
4.
Poloyac, Samuel M., Robert B. Reynolds, Howard Yonas, & Mary E. Kerr. (2004). Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. Journal of Neuroscience Methods. 144(2). 257–263. 43 indexed citations
5.
Poloyac, Samuel M., Michael A. Tortorici, Robert B. Reynolds, et al.. (2004). THE EFFECT OF ISONIAZID ON CYP2E1- AND CYP4A-MEDIATED HYDROXYLATION OF ARACHIDONIC ACID IN THE RAT LIVER AND KIDNEY. Drug Metabolism and Disposition. 32(7). 727–733. 38 indexed citations
6.
Goddette, Dean W., Terri Christianson, Beth F. Ladin, et al.. (1993). Strategy and implementation of a system for protein engineering. Journal of Biotechnology. 28(1). 41–54. 12 indexed citations
7.
Picataggio, Stephen, et al.. (1992). Metabolic Engineering of Candida Tropicalis for the Production of Long–Chain Dicarboxylic Acids. Nature Biotechnology. 10(8). 894–898. 207 indexed citations
8.
Reynolds, Robert B.. (1960). Retail Specialization of Central Business Districts. Journal of the American Institute of Planners. 26(4). 313–316. 1 indexed citations
9.
Reynolds, Robert B.. (1953). A Rejoinder. Journal of Marketing. 18(2). 172–174. 2 indexed citations
10.
Reynolds, Robert B.. (1953). [Comment on Movement of Retail Trade in Iowa]:A Rejoinder. Journal of Marketing. 18(2). 172–172. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026